Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Takato, Ueno"'
Autor:
Takuji Torimura, Hideki Iwamoto, Toru Nakamura, Mitsuhiko Abe, Yu Ikezono, Fumitaka Wada, Takahiko Sakaue, Hiroshi Masuda, Osamu Hashimoto, Hironori Koga, Takato Ueno, Hirohisa Yano
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 18, Iss 7, Pp 413-424 (2016)
BACKGROUND & AIM: Aflibercept known as ziv-aflibercept in the United States is a soluble decoy receptor of both vascular endothelial growth factor (VEGF) receptor-1 and -2 known to inhibit the binding of VEGF and placental growth factor (PlGF) to VEG
Externí odkaz:
https://doaj.org/article/9d6e7ac0e412484880ccd8e496cd4cd3
Autor:
Michio Sata, Hirohisa Yano, Takato Ueno, Hironori Koga, Osamu Hashimoto, Mitsuhiko Abe, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Takuji Torimura, Kinya Inoue
PDF file, 68KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8233598ac3c48ec15fd0196b64d8708a
https://doi.org/10.1158/1078-0432.22444368
https://doi.org/10.1158/1078-0432.22444368
Autor:
Michio Sata, Hirohisa Yano, Takato Ueno, Hironori Koga, Osamu Hashimoto, Mitsuhiko Abe, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Takuji Torimura, Kinya Inoue
Purpose: VEGF, EGF, and TGF-α are expressed in hepatocellular carcinomas (HCC) and play a role in its growth. Vandetanib, a multikinase inhibitor, suppresses the phosphorylation of VEGF receptor 2 (VEGFR-2) and EGF receptor (EGFR). The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68597a88ece1723002481b36d0251e68
https://doi.org/10.1158/1078-0432.c.6520143
https://doi.org/10.1158/1078-0432.c.6520143
Autor:
Michio Sata, Hirohisa Yano, Takato Ueno, Hironori Koga, Osamu Hashimoto, Mitsuhiko Abe, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Takuji Torimura, Kinya Inoue
PDF file, 143KB, Vandetanib inhibits tumor growth in the liver of nude mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3cf5c147f6928a26ef19c2a58733f8
https://doi.org/10.1158/1078-0432.22444371
https://doi.org/10.1158/1078-0432.22444371
Autor:
Michio Sata, Hirohisa Yano, Takato Ueno, Hironori Koga, Osamu Hashimoto, Mitsuhiko Abe, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Takuji Torimura, Kinya Inoue
PDF file, 128KB, Inhibitory effect of vandetanib on cell proliferation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6f474bee0ad73c8f6b6d2fc73bfb8d
https://doi.org/10.1158/1078-0432.22444380.v1
https://doi.org/10.1158/1078-0432.22444380.v1
Autor:
Michio Sata, Hirohisa Yano, Takato Ueno, Hironori Koga, Osamu Hashimoto, Mitsuhiko Abe, Hiroshi Masuda, Hideki Iwamoto, Toru Nakamura, Takuji Torimura, Kinya Inoue
PDF file, 82KB, Inhibitory effect of vandetanib on phosphorylation of EGFR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a86dd40df1318e66f41428848e5c07
https://doi.org/10.1158/1078-0432.22444377
https://doi.org/10.1158/1078-0432.22444377
Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis
Autor:
Toru Nakamura, Hironori Koga, Hideki Iwamoto, Victor Tsutsumi, Yasuko Imamura, Masako Naitou, Atsutaka Masuda, Yu Ikezono, Mitsuhiko Abe, Fumitaka Wada, Takahiko Sakaue, Takato Ueno, Masaaki Ii, Cantas Alev, Atsuhiko Kawamoto, Takayuki Asahara, Takuji Torimura
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Ex vivo expansion of autologous cells is indispensable for cell transplantation therapy of patients with liver cirrhosis. The aim of this study was to investigate the efficacy of human ex vivo-expanded CD34+ cells for treatment of cirrhotic rat liver
Externí odkaz:
https://doaj.org/article/ba8dfbdb893c47a8b0a8c5883ae2f795
Autor:
Hideki Iwamoto, Takuji Torimura, Toru Nakamura, Osamu Hashimoto, Kinya Inoue, Junichi Kurogi, Takashi Niizeki, Reiichiro Kuwahara, Mitsuhiko Abe, Hiromori Koga, Hirohisa Yano, Robert S. Kerbel, Takato Ueno, Michio Sata
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 13, Iss 3, Pp 187-197 (2011)
Background: Metronomic chemotherapy involves frequent, regular administration of cytotoxic drugs at nontoxic doses, usually without prolonged breaks. We investigated the therapeutic efficacies of metronomic S-1, an oral 5-fluorouracil prodrug, and va
Externí odkaz:
https://doaj.org/article/c4c89742d45e427cb9f56444dccd5816
Autor:
Hideki, Iwamoto, Takashi, Niizeki, Hiroaki, Nagamatsu, Kazuomi, Ueshima, Takako, Nomura, Teiji, Kuzuya, Kazuhiro, Kasai, Yohei, Kooka, Atsushi, Hiraoka, Rie, Sugimoto, Takehiro, Yonezawa, Akio, Ishihara, Akihiro, Deguchi, Hirotaka, Arai, Shigeo, Shimose, Tomotake, Shirono, Masahito, Nakano, Shusuke, Okamura, Yu, Noda, Naoki, Kamachi, Miwa, Sakai, Hiroyuki, Suzuki, Hajime, Aino, Norito, Matsukuma, Satoru, Matsugaki, Kei, Ogata, Yoichi, Yano, Takato, Ueno, Masahiko, Kajiwara, Satoshi, Itano, Kunitaka, Fukuizumi, Hiroshi, Kawano, Kazunori, Noguchi, Masatoshi, Tanaka, Taizo, Yamaguchi, Ryoko, Kuromatsu, Atsushi, Kawaguchi, Hironori, Koga, Takuji, Torimura, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan
Publikováno v:
Cancers
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 646, p 646 (2021)
Volume 13
Issue 4
BACKROUND: Not all patients with hepatocellular carcinoma (HCC) benefit from treatment with molecular targeted agents such as sorafenib. We investigated whether New-FP (fine-powder cisplatin and 5-fluorouracil), a hepatic arterial infusion chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f1483325e31a608b20b62e39c0d540
https://pubmed.ncbi.nlm.nih.gov/33562793
https://pubmed.ncbi.nlm.nih.gov/33562793
Autor:
Yuji Umeki, Yoshiaki Tanaka, Minoru Suzuki, Masami Hayashi, Ritsuko Torigoe, Yuko Kitajima, Takato Ueno, Saori Akiduki, Ayako Kamimura, Kouji Shinozaki, Kimie Sasaki
Publikováno v:
The Japanese Journal of SURGICAL METABOLISM and NUTRITION. 52:55-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f89a10d11ee53b0af7210e39872c4b5
https://doi.org/10.11638/jssmn.52.1_55
https://doi.org/10.11638/jssmn.52.1_55